BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2982003)

  • 1. TDI-induced oculorhinitis and bronchial asthma.
    Paggiaro PL; Rossi O; Lastrucci L; Pardi F; Pezzini A; Baschieri L
    J Occup Med; 1985 Jan; 27(1):51-2. PubMed ID: 2982003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific bronchial provocation tests in occupational asthma and methods of stimulation: case report.
    Moscato G; Biscaldi G; Cottica D; Candura F
    G Ital Med Lav; 1983 Nov; 5(6):259-61. PubMed ID: 6100489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occupational toluene diisocyanate (TDI) asthma--inhalation challenge test and TDI-HSA (human serum albumin) skin test and detection of specific IgE].
    Duan YY
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Jun; 12(3):149-52, 191. PubMed ID: 2553281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toluene diisocyanate-induced asthma without airway hyperresponsiveness.
    Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM
    Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS; Nahm DH
    Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late, but not early, asthmatic reactions induced by toluene-diisocyanate are associated with increased airway responsiveness to methacholine.
    Mapp CE; Di Giacomo GR; Omini C; Broseghini C; Fabbri LM
    Eur J Respir Dis; 1986 Oct; 69(4):276-84. PubMed ID: 3028853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma.
    Choi JH; Nahm DH; Kim SH; Kim YS; Suh CH; Park HS; Ahn SW
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):293-8. PubMed ID: 15478392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent airways disease caused by toluene diisocyanate.
    Moller DR; McKay RT; Bernstein IL; Brooks SM
    Am Rev Respir Dis; 1986 Jul; 134(1):175-6. PubMed ID: 3014935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthma].
    Marabini A; Brugnami G; Curradi F; Severini C; Siracusa A
    Med Lav; 1994; 85(2):134-41. PubMed ID: 8072441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroimmunological characteristics of Korean workers exposed to toluene diisocyanate.
    Kim H; Kim YD; Choi J
    Environ Res; 1997 Oct; 75(1):1-6. PubMed ID: 9356188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in blood eosinophils and nonspecific bronchial reactivity after exposure tests to wheat flour and TDI].
    De Zotti R; Gubian F; Negro C
    Med Lav; 1996; 87(2):152-61. PubMed ID: 8926918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective and immunologic study of factory workers exposed to TDI (toluene diisocyanate).
    Duce F; de Gregorio MA; Pérez J; Portillo JR; Pascual G; Alfonso ER
    Allergol Immunopathol (Madr); 1988; 16(3):139-44. PubMed ID: 2845764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diseases caused by diisocyanates. 2. Diisocyanate asthma].
    Lubach D
    Derm Beruf Umwelt; 1979; 27(1):5-10. PubMed ID: 226341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toluene diisocyanate asthma. 1. Clinico-immunological evaluation].
    Kido T; Yamada Y; Teranishi H; Daimon N; Shimizu T
    Arerugi; 1983 Feb; 32(2):111-20. PubMed ID: 6311143
    [No Abstract]   [Full Text] [Related]  

  • 15. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma.
    Choi JH; Lee KW; Kim CW; Park CS; Lee HY; Hur GY; Kim SH; Hong CS; Jang AS; Park HS
    Int Arch Allergy Immunol; 2009; 150(2):156-63. PubMed ID: 19439981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates.
    Mapp CE; Boschetto P; Zocca E; Milani GF; Pivirotto F; Tegazzin V; Fabbri LM
    Bull Eur Physiopathol Respir; 1987; 23(6):583-6. PubMed ID: 2840139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case of TDI-induced reactive airway dysfunction syndrome with the presence of specific IgE antibodies.
    Palczyński C; Górski P; Jakubowski J
    Allergol Immunopathol (Madr); 1994; 22(2):80-2. PubMed ID: 8059679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of an animal model for TDI asthma.
    Karol MH
    Bull Eur Physiopathol Respir; 1987; 23(6):571-6. PubMed ID: 2456109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological evaluation of isocyanate-exposed workers.
    Park HS; Park JN; Kim JW; Kim SK
    J Korean Med Sci; 1992 Jun; 7(2):122-7. PubMed ID: 1326284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isophorone diisocyanate induced respiratory disease (IPDI).
    Clarke CW; Aldons PM
    Aust N Z J Med; 1981 Jun; 11(3):290-2. PubMed ID: 6945844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.